Immediate Impact
2 hit
Citing Papers
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
2022 Hit
COVID-19 vaccine development: milestones, lessons and prospects
2022 Hit
Works of Daniel Naumovas being referenced
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
2021